prodisc Total Disc Replacement

The treatment goal of the prodisc C Total Disc Replacement is to restore the normal dynamic function of the spine and to significantly reduce pain.

The function of the spine is restored through the mechanism of action of the device. Pain reduction is achieved through the re-establishment of the disc height, and maintained by the prosthesis. The increase in height and the elimination of the herniated disc “opens” constricted nerve paths and the vertebral joints are restored to their physiological position.

Prior to the development of artificial discs the only surgical option was a fusion, in which adjacent vertebral bodies are “fused together” permanently using implants, bone chips and/or cages. The goal of prodisc C is to maintain mobility at the affected intervertebral disc and to reduce the extra loading on the adjacent intervertebral discs.

The most studied tdr system in the world.

Beginning with clinical usage in 1990, the prodisc design has been validated with over 125,000 device implantations worldwide and more than 540 published papers.

The prodisc C Total Disc Replacement has been determined to be safe and effective in the treatment of intractable symptomatic cervical disc disease (SCDD) at one level from C3 to C7.

The prodisc C Total Disc Replacement surgery is intended to:

• Remove the diseased disc
• Restore normal disc height
• Decompress surrounding neural structures
• Potentially provide motion in affected vertebral segment
• Improve patient function

The vertebral bodies encase the spinal cord to provide protection. When stacked on top of each other, they form the spinal column which provides stability for the head and upper body. The spinal cord and the nerve exits are located within the spinal canal.

The intervertebral discs are located between the vertebral bodies. These discs cushion shock forces, acting as “shock absorbers”. The discs in conjunction with the vertebral joints facilitate motion by turning, stretching and bending of the neck.

• prodisc L has a very long clinical history (25+ years) and has been widely used throughout the world. The prodisc line of total disc replacements (TDRs) are the most widely studied TDRs, with over 400 peer-reviewed published studies, reporting on over 13,000 patients. The first implantation of a prodisc L took place in 1990, and the second generation design received US PMA approval in 2006.
• This page outlines some of the clinical studies, biomechanical, and cost-effectiveness evaluations that have been published on prodisc L.
• No other disc replacement system has been studied more: nearly 40% of all TDR papers report on prodisc. More published lives than for any other system with over 13,000 patients reported on in over 400 articles.
• The prodisc design has been validated with over 125,000 device implantations and a reported reoperation rate of less than 1%.